MedPath

Comprehensive Functional Assessments for NOCAD

Completed
Conditions
Coronary Artery Disease
Myocardial Ischemia
Coronary Microvascular Dysfunction
Interventions
Device: coronary physiological indices
Registration Number
NCT06175572
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

To validate and investigate the efficacy of comprehensive functional assessments for the diagnostic and prognostic value in NOCAD.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1000
Inclusion Criteria
  1. visual evaluation of epicardial coronary artery diameter stenosis (DS%) ≤ 50%;
  2. CZT-SPECT was successfully conducted within three days of CAG
Exclusion Criteria
  1. had flow-limiting epicardial stenosis (DS% >50%) or angiography-derived FFR (Angio-FFR) ≤ 0.8;
  2. severe valvular heart disease;
  3. chronic heart failure and/or left ventricular ejection fraction (LVEF) of < 50%;
  4. cardiomyopathy and myocarditis;
  5. severe renal or hepatic insufficiency;
  6. failure in detecting SPECT;
  7. failure in computing Angio-IMR, and -FFR.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CSF cohortcoronary physiological indicesCoronary slow-flow patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT).
ANOCA cohortcoronary physiological indicesAngina with nonobstructive coronary artery patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT).
INOCA cohortcoronary physiological indicesIschemia with nonobstructive coronary artery patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT).
NCF cohortcoronary physiological indicesNormanl coronary-flow patients referred to coronary angiography and undergo assessment with single photon emission computed tomography imaging (SPECT).
Primary Outcome Measures
NameTimeMethod
Major adverse cardiac events (MACE)5 years

The composite of coronary heart disease death, nonfatal myocardial infarction, hospitalization for unstable angina, or fatal or nonfatal ischemic stroke.

Secondary Outcome Measures
NameTimeMethod
Individual components of MACE5 years

Cumulative incidence of the individual components of MACE

the change in Seattle Angina Questionnaire (SAQ) summary score5 years

The SAQ comprises 5 components namely physical limitation, angina stability, angina frequency, treatment satisfaction, and quality of life; these are then incorporated into the summary score. The higher the score, the better the patient's quality of life and physical function.

the change in Seattle Angina Questionnaire (SAQ) score of indivadual scale5 years

The SAQ comprises 5 components namely physical limitation, angina stability, angina frequency, treatment satisfaction, and quality of life. The higher the score, the better the patient's quality of life or physical function.

Trial Locations

Locations (1)

Zhongshan hospital, Fudan university

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath